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Abstract
The purpose of the study was to determine whether older (‡65 years) and younger (<65 years) women present-
ing to the emergency department (ED) with symptoms suggestive of acute coronary syndrome (ACS) varied on
risk factors, comorbid conditions, functional status, and symptoms that have implications for emergent cardiac
care. Women admitted to five EDs were enrolled. The ACS Symptom Checklist was used to measure symptoms.
Comorbid conditions and functional status were measured with the Charlson Comorbidity Index and Duke Activ-
ity Status Index. Logistic regression models were used to evaluate symptom differences in older and younger
women adjusting for ACS diagnosis, functional status, body mass index (BMI), and comorbid conditions. Analyses
were stratified by age, and interaction of symptom by age was tested. Four hundred women were enrolled.
Mean age was 61.3 years (range 21–98). Older women (n = 163) were more likely to have hypertension, hyper-
cholesterolemia, never smoked, lower BMI, more comorbid conditions, and lower functional status. Younger
women (n = 237) were more likely to be members of minority groups, be college-educated, and have a non-
ACS discharge diagnosis. Younger women had higher odds of experiencing chest discomfort, chest pain,
chest pressure, shortness of breath, nausea, sweating, and palpitations. Lack of chest symptoms and shortness
of breath (key symptoms triggering a decision to seek emergency care) may cause older women to delay seeking
treatment, placing them at risk for poorer outcomes. Younger African American women may require more com-
prehensive risk reduction strategies and symptom management.
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Introduction
Despite advances in medical care and treatment, the
burden of heart disease in the United States remains
high, and women bear a disproportionate amount.1
Heart disease claims more women’s lives than all forms
of cancer combined and is responsible for one in three
deaths among women.1 Despite these troubling statistics,
many women believe that heart disease is a man’s dis-
ease and underestimate their own risk. In 2013, Mosca
reported that only 57% of women were aware that
heart disease is their primary health threat.2 The level
of heart disease awareness among African American
and Hispanic women was 36% and 34%, respectively
(similar to the level of white women in 1997).2 Women
aged 55 years or less comprise almost one-fifth of all
cases of acute coronary syndrome (ACS).3 Paradoxi-
cally, younger women have higher mortality rates from
ACS than age-matched men and older women,4 which
Izadnegahdar et al. suggested is likely related to wors-
ening cardiac risk factors, including obesity, smok-
ing, hypertension, and diabetes. Recently, Hayes et al.
reported that spontaneous coronary artery dissection
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may account for up to 35% of myocardial infarctions
(MIs) in women £50 years.5
After age 65, the risk of heart disease in women is
equivalent to men, with women experiencing MI at
an average age of 71.7 years.6 Risk factors unique to
older women include menopause, hormone replace-
ment therapy, and previous treatment for breast can-
cer.7,8 Several risk factors related to pregnancy have
been identified as affecting younger women. In a re-
view of associations between preterm delivery and fu-
ture maternal cardiovascular disease, Minissian et al.
suggested that abnormal responses to pregnancy were
a woman’s first physiological ‘‘stress test.’’9 Veerbeek
et al. found that 39% of women with pregnancy-induced
hypertension continued to have elevated blood pressure
in the postpartum period.10 Gestational diabetes has also
been linked to an increased lifetime risk of type 2 dia-
betes (T2DM), a coronary heart disease equivalent. In
a study of 2787 women in the Coronary Artery Risk
Development in Young Adults Study (CARDIA), a his-
tory of gestational diabetes was a marker for early athero-
sclerosis independent of prepregnancy obesity among
women who had not developed T2DM or metabolic
syndrome.11 These findings suggest that older women
who experienced abnormal pregnancies earlier in life
may be at added risk for ACS.
Younger women are in danger of failing to recognize
ACS symptoms and reacting rapidly.12 Prior studies
demonstrated that younger women experience pro-
dromal symptoms more often than older women be-
fore an episode of ACS.13,14 Younger women also
experience a more diverse range of symptoms, from
pain or discomfort in the chest, neck, or jaw, to sweat-
ing, fatigue, and dizziness; however, chest pain or dis-
comfort remains the most prevalent symptom.15 In
contrast, women ‡65 years with ACS have been shown
to experience fewer symptoms, less chest pain, and
more dyspnea than younger women.16 Many studies
of symptoms of ACS focused on sex differences,17
but few focused on how symptoms may vary between
older and younger women.16 It is important to deter-
mine (1) how symptoms experienced by older and
younger women vary during an episode of potential
ACS, (2) whether differences in symptoms are signif-
icant enough to warrant intervention, and (3) what in-
terventions would be appropriate to improve clinical
and patient outcomes.
The purpose of this study was to determine whether
older (‡65 years) and younger (<65 years) women
presenting to the emergency department (ED) with
suspected ACS varied on risk factors, comorbid condi-
tions, functional status, and symptoms. ‘‘Older’’ was
defined as ‡65 years because women are eligible for
Medicare insurance at age 65, prehospital delay times
for potential ACS are increased for this group,18 and
the risk of heart disease reaches parity for women
and men at this age.6
Materials and Methods
This analysis is part of a larger prospective, multicenter
study examining the influence of gender on symptom
characteristics during ACS.19 Patients were enrolled at
five large referral centers in the Midwest, West, South-
west, and the Pacific Northwest regions of the United
States. The centers included four academic medical cen-
ters and a large referral community medical center.
Approval from all five institutional review boards and
the sponsoring institution was received before the start
of the study. Each institutional review board approved
a waiver of initial consent for electronic screening of pa-
tients and to collect initial symptom data before enroll-
ment. A waiver of initial consent was granted because
the main study aimwas to evaluate symptoms on presen-
tation to the ED and because of the emergent nature of
patients presenting with possible ACS. All patients gave
written, informed consent before enrollment in the
study. Symptom data were destroyed if patients declined
to participate.
Study population
Women and men presenting to the ED between Janu-
ary 2011 and December 2013 were enrolled. Inclusion
criteria were symptoms resulting in a cardiac evalua-
tion, fluent in English or Spanish, ‡21 years, and self-
presented or were transported by emergency medical ser-
vices. Patients were excluded if they had an exacerbation
of heart failure, were transferred from a hemodialysis
unit, were referred for evaluation of a dysrhythmia,
or had cognitive impairment. A targeted sampling
plan was employed because most patients presenting
to the ED for symptoms suggestive of ACS will rule-
out. Patients most likely to rule-in were identified by
research staff before enrollment, based on electrocar-
diogram (ECG) and troponin criteria. Research staff
approached patients with a troponin level outside
the referenced norm for the institution and/or with
any ECG changes suggestive of ischemia for enroll-
ment. Ischemia was defined as T-wave inversion, ST-
depression, or ST-elevation ‡1mm in two contiguous
leads (except for V2–V3, which have cut points of
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‡2mm for men ‡40 years, ‡1.5mm for men <40 years,
and ‡2.5mm for women).20
Measures
Demographic data. Demographic measures included
age, sex, education, income, marital status, and income.
ACS patient information questionnaire. This demo-
graphic and clinical questionnaire was designed by
using the standardized reporting guidelines for studies
evaluating risk stratification of ED patients with poten-
tial ACS.21 The criteria were established by the Multi-
disciplinary Standardized Reporting Criteria Task
Force and are supported by the Society for Academic
Emergency Medicine, American College of Emergency
Physicians, American Heart Association (AHA), and
American College of Cardiology (ACC). The purpose
of the document is to establish standardized reporting
criteria that will more easily allow for study compari-
sons and meta-analyses, one of the rationales for the
proposed study. The questionnaire takes about 10min
to complete. It was used to generate appropriate de-
scriptive statistics for the sample.
The ACS Symptom Checklist. The ACS Symptom
Checklist is a 13-item empirically derived instrument
that measures the symptoms of ACS. The ACS Symp-
tom Checklist has demonstrated reliability and validity
in prior studies.22,23 Participants indicate whether the
symptom is present or absent. Other symptoms can
be recorded in a blank space marked ‘‘other.’’ Each
symptom is analyzed individually, and there is no sum-
mary score.
Charlson Comorbidity Index. The 19-item weighted
index is the most extensively studied method of quan-
tifying risk associated with comorbid conditions.24
Higher scores represent a greater burden of disease.
Studies have demonstrated that the Charlson Comor-
bidity Index (CCI) is a valid measure for predicting dis-
ability and death after ischemic stroke and heart
disease,25 as well as for in-hospital and 1-year outcomes
in patients with ACS.26
Duke Activity Status Index. The Duke Activity Status
Index (DASI) is a brief 12-item instrument that mea-
sures functional capacity.27 Scores range from 0 to
58.2, with higher scores representing better physical
functioning. The items on the scale are weighted to re-
flect metabolic energy expenditure and correlate highly
with peak VO2 (r = 0.80, p < 0.0001) in patients with
ACS28 and ischemic heart disease.29 Concurrent valid-
ity was supported by correlations with measures of
physical functioning (r = 0.69, p< 0.05 and r = 0.61,
p< 0.05).30
Procedures
The ACS symptom checklist was completed by a mem-
ber of the research staff when the patient arrived in ED
triage. In most cases, symptoms were assessed within
15min of presentation. Patients were approached by
the research staff for enrollment after they were moved
to an ED examination room or to a cardiac bed in
the hospital. The study was explained by a member
of the research staff, and, once the patient provided
written informed consent, additional clinical and in-
dividual characteristics were recorded. If the patient
declined to participate, the ACS symptom checklist
was shredded.
Statistical analysis
Study data were entered into SPSS (IBM SPSS Statistics
for Windows, version 24.0, IBM Corp., Armonk, NY)
by a research assistant and transferred to SAS (version
9.3; Cary, NC) for analysis. Significance was set at
p< 0.05 for all statistical procedures. Normally distrib-
uted continuous variables were described with means,
and independent-sample t tests or analysis of variance
were performed. Categorical data were described with
frequencies and compared across diagnostic categories
with the Chi-square test for independence.
Logistic regression models were used to evaluate
symptom differences in older and younger women,
adjusting for ACS diagnosis, functional status, body
mass index (BMI), and comorbid conditions. Analy-
ses of symptoms were stratified by age, and interaction
of symptom by age was tested. Potential covariates
were chosen because of reports of gender differences
in prior studies31–33 and because obesity,17 diabetes,34
and functional status35 can confound the symptom
experience.
Results
Demographics
The sample (n = 400) included 237 women <65 years
and 163 women ‡65 years. Mean age was 61.3 years
(range 21–98 years). Younger women were more
likely to be members of minority groups (36.2% vs.
25.9%), have a higher level of education ( p = 0.028),
and have a non-ACS discharge diagnosis (70.9% vs.
62.0%; Table 1).
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Comorbid conditions and functional status
Older women (n = 163), compared with younger
women, were more likely to have hypertension ( p<
0.001), hypercholesterolemia ( p= 0.003), never smoked
( p< 0.001), a lower BMI ( p= 0.001), more comorbid
conditions ( p< 0.001), and lower functional status
( p< 0.001). Younger women (n= 237) were more likely
to be members of minority groups ( p= 0.042), be
college-educated ( p= 0.028), and to have a non-ACS
discharge diagnosis (0.048). Younger women also had
higher odds of experiencing chest discomfort (odds
ratio; OR= 2.50, 95% confidence interval; CI= 1.51–
4.15), chest pain (OR= 1.65, 95% CI= 1.02–2.65), chest
pressure (OR = 2.21, 95% CI= 1.36–3.58), shortness
of breath (OR = 2.21, 95% CI = 1.36–3.58), nausea
(OR = 1.80, 95% CI= 1.12–2.87), sweating (OR = 1.87,
95% CI = 1.15–3.04), and palpitations (OR = 1.79, 95%
CI= 1.08–2.97).
As expected, older women were more likely to have
hypercholesterolemia (64% vs. 49.1%) and hyperten-
sion (73.1% vs. 54.5%), as well as higher mean scores
on the CCI (2.3 – 2.0 vs. 1.4 – 1.7). Younger women
had higher BMI (31.3– 8.9 vs. 28.5 – 6.8), were more
likely to smoke (21.5% vs. 5.6%), and had higher phys-
ical functioning as measured by the DASI (34.1– 19.5
vs. 23.1– 16.5; Table 1).
Symptom differences
In unadjusted analyses, older women, compared with
younger women, were less likely to report 9 of 13 symp-
toms: chest discomfort, chest pain, chest pressure, short-
ness of breath, nausea, armpain, sweating, shoulder pain,
and palpitations (Table 2). After adjusting for diagnosis,
CCI, DASI, and BMI, arm and shoulder pain were no
longer significantly different between older and younger
women. Younger women had higher odds of experienc-
ing chest discomfort (OR= 2.46, 95% CI= 1.48–4.09),
chest pain (OR= 1.63, 95% CI= 1.01–2.63), chest pres-
sure (OR= 2.42, 95% CI= 1.48–3.96), shortness of
breath (OR= 2.15, 95% CI= 1.32–3.49), nausea (OR=
1.73, 95% CI = 1.08–2.78), sweating (OR = 1.85, 95%
CI = 1.13–3.03), and palpitations (OR = 1.78, 95%
CI = 1.07–2.97; Fig. 1).
In unadjusted analyses, older women reported fewer
symptoms than younger women in 9 of 12 symptoms
measured. After adjusting for variables that are known
to confound the symptom experience (comorbid condi-
tions,36 functional status,35 and diabetes37), the only dif-
ference in findings was that arm and shoulder pain were
not reported more frequently by younger women. Arm
pain was the second most reported symptom, after
chest pain, in a cohort of women with spontaneous cor-
onary artery dissection,38 and, in another study, women
with arm pain had higher odds of an ACS diagnosis com-
pared with men.39
Table 1. Demographic and Clinical Characteristics
of the Sample
Characteristic
<65 Years ‡65 Years
pn= 237 (%) n= 163 (%)
Race/ethnicity [n (%)] 0.042
African American 40 (17.2) 21 (13.0)
White-non Hispanic 150 (64.7) 120 (74.1)
Hispanic 14 (6.0) 13 (8.0)
Other 28 (12.1) 8 (4.9)
Education, n (%) 0.028
Less than high school diploma 22 (9.4) 30 (18.4)
High school diploma 47 (20.1) 41 (25.2)
Some college 81 (34.6) 45 (27.6)
College degree/Graduate work 57 (24.4) 28 (17.2)
Graduate degree 27 (11.5) 19 (11.7)
Diagnosis 0.048
Non-ACS 165 (71.1) 100 (61.7)
Unstable angina 20 (8.6) 10 (6.2)
NSTEMI 33 (14.2) 40 (24.7)
STEMI 14 (6.0) 12 (7.4)
BMI [mean (SD)] 31.3 (8.9) 28.5 (6.8) 0.001
Smoking status, n (%) <0.001
Never 133 (58.3) 108 (67.5)
Former 46 (20.2) 43 (26.9)
Current smoker 49 (21.5) 9 (5.6)
Hypertension, n (%) 127 (54.7) 117 (73.1) <0.001
Hypercholesterolemia, n (%) 113 (48.9) 103 (64.0) 0.003
CCI Score, mean (SD) 1.4 (1.7) 2.3 (2.0) <0.001
DASI Score, mean (SD) 34.0 (19.6) 23.1 (16.5) <0.001
ACS, acute coronary syndrome; BMI, body mass index; CCI, Charlson
Comorbidity Index; DASI, Duke Activity Status Index; NSTEMI, non-ST
elevation myocardial infarction; SD, standard deviation; STEMI,
ST-elevation myocardial infarction.
Table 2. Unadjusted Symptom Differences by Age Group
Symptoma
<65 Years ‡65 Years
pn= 237 (%) n =163 (%)
Chest discomfort 191 (80.6) 94 (57.7) <0.001
Chest pain 174 (73.4) 92 (56.4) <0.001
Chest pressure 181 (76.4) 90 (55.2) <0.001
Short of breath 160 (67.5) 85 (52.1) 0.002
Unusual fatigue 119 (50.2) 81 (49.7) 0.919
Lightheadedness 126 (53.2) 75 (46.3) 0.178
Nausea 116 (48.9) 60 (36.8) 0.016
Arm pain 103 (43.5) 53 (32.5) 0.027
Sweating 98 (41.4) 44 (27.0) 0.003
Shoulder pain 107 (45.1) 53 (32.5) 0.011
Upper back pain 94 (39.7) 56 (34.4) 0.281
Palpitations 92 (38.8) 38 (23.3) 0.001
Indigestion 67 (28.3) 38 (23.3) 0.268
aSymptoms are listed in order of most frequently to least frequently
reported.
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Discussion
Congruent with previous studies,40 there were differ-
ences in risk factors, comorbid conditions, and symp-
toms between older and younger women in our
study. Key findings included that older women were
more likely to have hypertension, hypercholesterol-
emia, never smoked, lower mean BMI, more comorbid
conditions, and poorer functional status. Younger
women were more likely to be members of minority
groups, be college-educated, and have a non-ACS dis-
charge diagnosis. Younger women had higher odds of
experiencing chest discomfort, chest pain, chest pres-
sure, shortness of breath, nausea, sweating, and palpita-
tions after adjusting for covariates.
Risk factors and comorbid conditions may contrib-
ute to poorer patient-centered outcomes for both
groups of women, including confusion over the cause
of symptoms and delay in presentation to the ED.
These factors may also contribute to breakdowns in
clinical care, such as prolonged time to ECG acquisi-
tion, inappropriate cardiac catheterization laboratory
activation, or missed ACS diagnosis. As anticipated,
we found that older women were more likely to have
risk factors, comorbid conditions, and poorer physical
functioning compared with younger women. These
factors may disadvantage older women who experience
symptoms of ACS because they may misinterpret
symptoms and attribute them to a nonemergent condi-
tion41 or to the aging process.42 Women may also be
unaware of their risk for heart disease2 or lack knowl-
edge43 of symptoms. Risk factors associated with preg-
nancy (including pregnancy-induced hypertension,44
gestational diabetes,45,46 and preterm delivery47) are as-
sociated with additional risk for future cardiovascular
disease; however, it remains unclear as to whether
these risks contribute to symptom differences for older
versus younger women.
The increased prevalence of comorbidities in women
plays a key role in their risk of cardiovascular disease.
Prevalence of obesity is on the rise worldwide,48 and
cardiovascular disease occurs at a younger age in
obese women than nonobese women.49 Obese women
experience more metabolic disorders such as hyperlip-
idemia, T2DM, and insulin resistance.49 Vishram et al.
found that the prevalence of metabolic syndrome in-
creased fivefold in women from age 19 to 79.50 Obese
women also experience greater increases in systolic
and diastolic blood pressure compared with women
with a normal BMI.51 This may partly explain why
younger women in our sample were more likely to be
FIG. 1. Adjusted odds of reporting a symptom for younger compared with older women. Symptoms
are listed in order of most frequently to least frequently reported. Adjusted for acute coronary syndrome
diagnosis, Charlson Comorbidity Index, Duke Activity Status Index, and body mass index. *Statistically
significant difference.
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members of a minority, given the higher prevalence of
obesity in African American and Hispanic women.52
Hypertension is another comorbidity adversely affecting
women. In 2017, the proportion of women aged 45–54
years with hypertension was estimated to be 33%,53 and
62% of Americans with hypertension are female.54 The
incidence of hypertension in postmenopausal women
is four times higher than in premenopausal women.53
Finally, although smoking is a well-known and modifi-
able risk factor, middle-aged women who smoke have a
sixfold increased risk of cardiovascular disease com-
pared with a threefold increased risk in men.54
Younger women may be at higher risk for a missed
ACS diagnosis. Clinicians may have a low suspicion
for ACS even in the presence of chest pain and associ-
ated symptoms, given the lower likelihood of ACS in
younger women.55 Previous studies have highlighted
significant disparities in acute cardiovascular care
among women, minorities, and the elderly.55 Younger
women are also at higher risk for failing to recognize
ACS symptoms and calling emergency medical ser-
vices,56 particularly minority women, given their lack
of awareness of their vulnerability to heart disease.2
Several heart disease awareness campaigns are attempt-
ing to increase women’s awareness of risk,57,58 but
progress is slow and Mosca et al. found that minority
women’s awareness of their risk of heart disease lags
behind that of white women.2 Efforts such as these
are necessary to equip women with information about
this disease and its associated traditional and nontradi-
tional risk factors and symptoms. Younger women in
our study were more highly educated, which may
have implications for future interventions targeted to
both younger and older women. Younger women who
are more highly educated and exposed to social media
may be more aware of cardiovascular risk factors and
their own susceptibility to heart disease. Our data on
symptom differences by age may help inform the design
of age-appropriate interventions for younger and older
women. Younger women can receive reinforcement of
their risk for heart disease before they develop ACS.
In contrast, older women may have a greater need for
information on timely treatment-seeking and symptom
recognition.
The fact that the older women in our sample experi-
enced less chest pain, pressure, and discomfort is con-
cerning from the perspective of the patient and clinicians
who may suspect alternative and less emergent diag-
noses, including gastric reflux or heartburn. Risks of
delayed presentation and care are salient given the
aging of the U.S. population. The number of Ameri-
cans aged 65 and older is projected to more than dou-
ble from 46 million in 2016 to more than 98 million
by 2060. The ‡65 age group will grow from 15% today
to 24% by 2060.59
Strengths and limitations
Symptom data were collected with a validated symptom
instrument on arrival to the ED triage, eliminating most
patient recall bias. A large heterogeneous sample was en-
rolled, suggesting that study findingsmay be generalizable
to other EDs and patients with symptoms suggestive of
ACS. Symptoms were self-reported by patients, which
has been shown to be more reliable than symptoms ab-
stracted from medical records.60 Self-report has also
been considered to be a limitation because there is no
way to validate the symptom event. Justice et al., how-
ever, noted that patients, not providers, experience symp-
toms and so are best able to describe them.61 We could
not determine the inter-rater reliability of ECG analyses
or whether the most recent AHA/ACC criteria (which
account for sex and age differences in ST-segment devi-
ations) were consistently used.20 Finally, we did not as-
sess reproductive history and, hence, do not know the
significance of pregnancy risks in our sample.
Conclusions
Lack of chest symptoms and shortness of breath, key
symptoms triggering a decision to seek emergent
care, may influence older women’s decision to delay
treatment, placing them at risk for poorer outcomes.
Younger African American women require more
comprehensive risk reduction strategies and symp-
tom management. Risk reduction strategies should
target young women, particularly those who have had
complications during pregnancy. Our findings reinforce
the importance of tailoring ED assessment for potential
ACS by age for women. Finally, the addition of non-
chest pain symptoms in risk stratification models may
be needed for older women.
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